Effect of alosetron on theophylline pharmacokinetics

British journal of clinical pharmacology

Volumn 52, Issue 5, 2001, Pages 596-600

  Koch, K M ^a   Ricci, B M ^a   Hedayetullah, N S ^b   Jewell, D ^b   Kersey, K E ^b  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; BRONCHODILATING AGENT; CARBOLINE DERIVATIVE; CYTOCHROME P450 1A2; SEROTONIN ANTAGONIST; THEOPHYLLINE;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG INTERACTION; FEMALE; HUMAN; METABOLISM; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AREA UNDER CURVE; BRONCHODILATOR AGENTS; CARBOLINES; CROSS-OVER STUDIES; CYTOCHROME P-450 CYP1A2; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; SEROTONIN ANTAGONISTS; THEOPHYLLINE;

EID: 0035515608     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0306-5251.2001.01477.x     Document Type: Article

References (0)